Nnamdi Etoh
@Rock Springs Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
UNHUnitedhealth Group Inc
| 5.6% | $172.042M 294,250 shares@ $584.68 avg price | Increased 7.01% |
ARGXArgenx Se
| 4.12% | $126.576M 233,500 shares@ $542.08 avg price | Increased 1.86% |
LLYEli Lilly & Co
| 4.1% | $125.803M 142,000 shares@ $885.94 avg price | Increased 16.88% |
RAREUltragenyx Pharmaceutical In
| 3.58% | $109.893M 1.978M shares@ $55.56 avg price | Increased 2.82% |
EXASExact Sciences Corp
| 2.55% | $78.168M 1.147M shares@ $68.12 avg price | Increased 6.11% |
TVTXTravere Therapeutics Inc
| 2.14% | $65.536M 4.684M shares@ $13.99 avg price | Increased 4.52% |
MDGLMadrigal Pharmaceuticals Inc
| 1.82% | $55.827M 263,062 shares@ $212.23 avg price | Increased 7.16% |
XENEXenon Pharmaceuticals Inc
| 1.69% | $51.83M 1.316M shares@ $39.37 avg price | Increased 3.43% |
WSTWest Pharmaceutical Svsc Inc
| 1.64% | $50.352M 167,750 shares@ $300.16 avg price | Increased 15.3% |
ASNDAscendis Pharma A S
| 1.58% | $48.526M 325,000 shares@ $149.31 avg price | Increased 12.07% |